0-2 year | ||||||||
---|---|---|---|---|---|---|---|---|
T2T (n=261) | UC (n=213) | UC from 2006 (n=69) | ||||||
Volume | Costs | Volume | Costs | Difference in costs | Volume | Costs | Difference in costs | |
Consultations rheumatologist | 10.4 ± 3.0 | 696 ± 199 | 10.3 ± 2.9 | 689 ± 195 | 7 | 10.2 ± 3.6 | 683 ± 239 | 13 |
Consultations nurse | 8.8 ± 3.0 | 588 ± 200 | 7.8 ± 1.9† | 522 ± 127† | 66 | 6.6 ± 2.0† | 438 ± 134† | 150 |
Telephonic consultations | 1.3 ± 1.8 | 34 ± 46 | 0.6 ± 1.4† | 16 ± 36† | 18 | 1.1 ± 1.9 | 29 ± 48 | 5 |
Hospital admissions | 0.4 ± 2.7 | 178 ± 1,208 | 1.1 ± 4.2† | 521 ± 1,901† | -343 | 0.3 ± 1.6 | 158 ± 714 | 20 |
Medication | ||||||||
DMARDs/other | 174 ± 165 | 249 ± 340 | -75 | 166 ± 119 | 8 | |||
Anti-TNF | 3,121 ± 7,162 | 1,730 ± 4,905† | 1,391 | 1,877 ± 5,086 | 1244 | |||
Total | 4,791 ± 7,436 | 3,727 ± 5,773 | 1,064 (1,026 to 1,121)‡ | 3,351 ± 5,179† | 1440 (1,387 to 1479)‡ | |||
0-3 year | ||||||||
T2T (n=127) | UC (n=180) | UC from 2006 (n=45) | ||||||
Volume | Costs | Volume | Costs | Difference in costs | Volume | Costs | Difference in costs | |
Consultations rheumatologist | 13.7 ± 3.3 | 917 ± 220 | 13.6 ± 3.3 | 909 ± 224 | 8 | 12.5 ± 3.8 | 838 ± 253† | 79 |
Consultations nurse | 12.1 ± 3.6 | 809 ± 244 | 8.9 ± 1.7† | 596 ± 117† | 213 | 8.4 ± 2.2† | 565 ± 145† | 244 |
Telephonic consultations | 1.9 ± 2.1 | 49 ± 54 | 0.8 ± 1.7† | 21 ± 45† | 28 | 1.7 ± 2.5 | 43 ± 64 | 6 |
Hospital admissions | 0.5 ± 3.2 | 215 ± 1,441 | 1.6 ± 5.0† | 748 ± 2,263† | -533 | 0.8 ± 2.7 | 364 ± 1,217 | -149 |
Medication | ||||||||
DMARDs/other | 260 ± 335 | 423 ± 612† | -163 | 259 ± 174 | 1 | |||
Anti-TNF | 4,160 ± 10,685 | 4,175 ± 10,070 | -15 | 5,488 ± 11,528 | -1,328 | |||
Total | 6,410 ± 10,845 | 6,872 ± 11,033 | -462 (-513 to -350)‡ | 7,558 ± 11,649 | -1,148 (-1241 to -1075)‡ |